Skip to content
Disclosery

EXANE DERIVATIVES: CI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 287 CI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 287 shares
    Change vs previous 13F +161 shares

    0.04% of the 13F portfolio, value $75,619.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 126 shares
    Change vs previous 13F +124 shares

    0.01% of the 13F portfolio, value $30,190.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2 shares
    Change vs previous 13F -5,649 shares

    <0.01% of the 13F portfolio, value $459.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 5,651 shares
    Change vs previous 13F -6 shares

    0.28% of the 13F portfolio, value $1,131,126.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 5,657 shares
    Change vs previous 13F +11 shares

    0.31% of the 13F portfolio, value $1,332,576.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 5,646 shares
    Change vs previous 13F -176 shares

    0.41% of the 13F portfolio, value $1,364,893.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 5,822 shares
    Change vs previous 13F +5,626 shares

    0.37% of the 13F portfolio, value $1,212,048.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 196 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $33,205.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).